DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cxbv45/research_report) has announced the addition of the "Research Report on China's Foot-and-mouth Disease (FMD) Vaccine Industry, 2010-2019" report to their offering.
As the world's largest pork producer and consumer, China contributes to nearly half of the total production. In 2014, meat production in China totaled 87.07 million tons, increasing 2.0% year on year. Specifically, pork production was 56.71 million tons with a year- on- year growth of 3.2%, beef production 6.89 million tons with a year- on- year growth of 2.4%, mutton production 4.28 million tons with a year- on- year growth of 4.9% and poultry production 17.51 million tons with a year- on- year decrease of 2.7%. In 2014, pig stocks amounted to 465.83 million, decreasing 1.7% year on year while the number of pigs ready for slaughter reached 735.10 million, increasing 2.7% year on year.
The outbreak of type A FMD happened in Guangdong, Henan and Anhui in 2012, Guangxi and Guangdong in 2013 and showed a South-to-North picture in 2014 autumn and winter, influencing such regions as Xizang, Guangxi, Jiangxi, Anhui, Shandong. And 2015 also witnessed many reports of FDM in China too. Therefore, getting livestock such as pigs, cattle and sheep vaccinated is very necessary.
According to the 2015 National Compulsory Immunization Program of Animal Disease issued by the Ministry of Agriculture of the People's Republic of China, compulsory vaccines for four animal diseases like FDM are funded by the government. Currently, the Chinese government invites bids for FDM vaccine before purchasing. Driven by intensive farming, big farms' demand for customized vaccine keeps growing, which leads to the fastened marketization of vaccinea. Besides, as direct selling features high technological barrier and few enterprises, there is not much competition in the market, leading to a high profit.
As the Chinese government has begun to emphasize the quality of compulsory vaccines, the bidding of such vaccines as FDM vaccines in Guangdong, Fujian and Shandong has implemented since 2013 the strategy of high quality at a favorable price. And it is estimated that procurement standards for compulsory vaccines will rise and so do their price.
As the Chinese economy develops, people's living standards keep rising, so do their demands for meat and dairy products. This stimulates the development of stock raising and the demand for the FMD vaccine. The market size of the FMD vaccine is expected to keep growing in China with a rate of over 20%.
Key Topics Covered:
2 Factors Affecting Development of FMD Vaccine in China, 2011-2015
3 Operation Status of FMD Vaccine Industry in China, 2010-2014
4 Major Producers of FMD Vaccine in China, 2011-2015
5 Purchase of FMD Vaccine by Some Local Governments in China, 2011-2015
6 Expectation to FMD Vaccine Industry in China, 2015-2019
- China Agricultural Vet.Bio. Science and Technology Co., Ltd
- Inner Mongolia Bi Wei Antai Biological Technology Co., Ltd
- QYH Biotech Co., Ltd
- Shen Lian Biotechnology Co., Ltd
- The Spirit Jinyu Biological Pharmaceutical Co., Ltd
For more information visit http://www.researchandmarkets.com/research/cxbv45/research_report